peter parker

Description

On Thursday, June 28, Sony Pictures Entertainment (NYSE: SNE) is joined by NYC Service to highlight the July 3rd premiere of the highly anticipated summer blockbuster, "The Amazing Spider-Man™." To mark this occasion, the group rings The Closing BellSM. NYC Service and Sony Pictures Entertainment worked together to create the "Be Amazing, Stand Up and Volunteer" program. The initiative aims to support Stand Up To Cancer, which funds accelerated and innovative cancer research. About Sony Pictures' "The Amazing Spider-Man" One of the world's most popular characters is back on the big screen as a new chapter in the Spider-Man legacy is revealed in The Amazing Spider-Man™. Focusing on an untold story that tells a different side of the Peter Parker story, the new film stars Andrew Garfield, Emma Stone, Rhys Ifans, Denis Leary, Campbell Scott, Irrfan Khan, with Martin Sheen and Sally Field. The film is directed by Marc Webb. The screenplay is by James Vanderbilt and Alvin Sargent and Steve Kloves from a story by James Vanderbilt, based on the Marvel Comic Book by Stan Lee and Steve Ditko. Laura Ziskin, Avi Arad, and Matt Tolmach are producing the film in association with Marvel Entertainment for Columbia Pictures, which will open in theaters everywhere in 3D on July 3, 2012. About Sony Pictures Entertainment (NYSE: SNE) Sony Pictures Entertainment (SPE) is a subsidiary of Sony Corporation of America, a subsidiary of Tokyo-based Sony Corporation. SPE's global operations encompass motion picture production and distribution; television production and distribution; home entertainment acquisition and distribution; a global channel network; digital content creation and distribution; operation of studio facilities; development of new entertainment products, services and technologies; and distribution of entertainment in more than 159 countries. About Stand Up To Cancer Stand Up To Cancer (SU2C)-a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization-raises funds to accelerate the pace of groundbreaking translational research that can get new therapies to patients quickly and save lives. SU2C facilitates collaboration among the best and the brightest in the cancer research community. The American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, Ph.D., conduct rigorous, competitive review processes through which SU2C's grantees are selected. By galvanizing the entertainment industry, SU2C generates awareness and builds grassroots support for this new approach to ending cancer.